Histopathological reporting of pT4 tumour stage in colorectal carcinomas: Dotting the 'i's and crossing the 't's

Journal of Clinical Pathology

Volumn 63, Issue 2, 2010, Pages 110-115

  Swamy, R ^a  

^a QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; COLORECTAL CARCINOMA; HISTOPATHOLOGY; HUMAN; MESOTHELIUM CELL; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR PERFORATION;

COLORECTAL NEOPLASMS; EPITHELIAL CELLS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEUM; SEROUS MEMBRANE;

EID: 77349091858     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.069658     Document Type: Review

References (36)

1. Sobin LH, Wittekind CH. UICC TNM classification of malignant tumors 6th edn. New York: Wiley-Liss, 2002.
2. Sobin LH, Wittekind CH. UICC TNM classification on malignant tumours 5th edn. New York: Wiley-Liss 1997.
3. DATASET Royal College of Pathologists Working Group on Cancer Services. Standards and minimum datasets for reporting common cancers. Minimum dataset for colorectal cancer histopathology reports London, UK: The Royal College of Pathologists, 2007.
4. Jass RJ, O'Brien MJ, Riddell RH, et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol 2007;38; 537-45.
5. Compton C, Fenoglio-Preiser CM, Pettigrew N, et al. American joint committee on cancer prognostic factors consensus conference: colorectal working group. Cancer 2000;88:1739-57.
6. Greene FL, Page DL, Fleming ID, et al, eds. AJCC cancer staging manual. 6th edn. NewYork, NY: Springer, 2002.
7. Puppa G, Sonzogni A, Pelosi G. For the sake of clarity about pT4 category of colorectal cancer [Letters to the Editor and in reply]. Arch Pathol Lab Med 2009;133; 340-1.
8. Washington MK, Berlin J, Branton PA, et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch Pathol Lab Med 2008;132;1182-93.
9. Quirke P, Morris E. Reporting colorectal cancer. Histopathology 2007;50:103-12.
10. Howarth SM, Morgan MJ, Williams GT. The new TNM classification of colorectal cancer a stage too far. (6th edition). Gut 2004;53:A21.
11. Goldstein NS, Turner JR. Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer 2000;88:2228-38.
12. Petersen VC, Baxter KJ, Love SB, et al. Identification of objective pathological prognostic determinants and models of prognosis in Duke's B colon cancer. Gut 2002;51:65-9.
13. Shepherd N, Baxter K, Love S. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997;112:1096-102.
14. Shepherd NA, Baxter KJ, Love SB. Influence of local peritoneal involvement on local recurrence and prognosis in rectal cancer. Therapy of resected colon carcinoma. J Clin Pathol 1995;48:849-55.
15. Ludeman L, Shepherd NA. Serosal involvement in gastrointestinal cancer: its assessment and significance. Histopathology 2005;47:123-31.
16. Carolyn C, Compton, Frederick L, et al. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004;54:295- 308.
17. Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698-702.
18. Newland R, Dent O, Lyttle M, et al. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis. Cancer 1994;73:2076-82.
19. Harrison JC, Dean PJ, el-Zeky F, et al. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol 1994;25:498-505.
20. Ludeman L, Shepherd NA. Macroscopic assessment and dissection of colorectal cancer resection specimens. Current Diagnostic Pathology 2006;12:220-30.
21. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2:996-9.
22. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
23. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335:1055-9.
24. Moertel CG, Fleming TR, MacDonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321-6.
25. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51.
26. Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005;352:2696-704.
27. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89:327-34.
28. Martling A, Singnomklao T, Holm T, et al. Prognostic significance of both surgical and pathological assessment of curative resection for rectal cancer. Br J Surg 2004;91:1040-5.
29. Sebag-Montefiore D, Glynne-Jones R, Mortensen N, et al. Pooled analysis of outcome measures including the histopathological R0 resection rate after preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis 2005;7(s1):7
30. Mawdsley S, Glynne-Jones R, Grainger J, et al. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 2005;63:745-52.
31. Luna-Perez P, Bustos-Cholico E, Alvarado I, et al. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection. J Surg Oncol 2005;90:20-5.
32. Bateman AC, Carr NJ, Warren BF. The retroperitoneal surface in distal caecal and proximal ascending colon carcinoma: the Cinderella surgical margin? J Clin Pathol 2005;58:426-8.
33. Quirke P, Guillou P, Thorpe H, et al. Circumferential surgical margins in rectum and right colon in the MRC CLASICC trial. 3 year disease-free survival and local recurrence. J Pathol 2006;208:30A
34. Chan K, Boey J, Wong S. A method of reporting radial invasion and surgical clearance of rectal carcinoma. Histopathology 1985;9:1319-27.
35. Quirke P, Scott N. The pathologist's role in the assessment of local recurrence in rectal carcinoma. Surg Oncol Clin N Am 1992;3:1-17.
36. Shepherd NA, Saraga EP, Love SB, et al. Prognostic factors in colonic cancer. Histopathology 1989;14:613-20.